Yves Bertrand

Ontology type: schema:Person     

Person Info





Publications in SciGraph latest 50 shown

  • 2019-03 Maximal concentration of intravenous busulfan as a determinant of veno-occlusive disease: a pharmacokinetic-pharmacodynamic analysis in 293 hematopoietic stem cell transplanted children in BONE MARROW TRANSPLANTATION
  • 2019-02 The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia in LEUKEMIA
  • 2018-08 Polycomb repressive complex 2 haploinsufficiency identifies a high-risk subgroup of pediatric acute myeloid leukemia in LEUKEMIA
  • 2018-01 Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials in LEUKEMIA
  • 2017-05 Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) in BONE MARROW TRANSPLANTATION
  • 2017-04 Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experience in BONE MARROW TRANSPLANTATION
  • 2017-04 A Nonparametric Method to Optimize Initial Drug Dosing and Attainment of a Target Exposure Interval: Concepts and Application to Busulfan in Pediatrics in CLINICAL PHARMACOKINETICS
  • 2017-01 Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study in BONE MARROW TRANSPLANTATION
  • 2017-01 Late effects in survivors of infantile acute leukemia: a study of the L.E.A program in BLOOD CANCER JOURNAL
  • 2016-12 Employment in French young adult survivors of childhood leukemia: an LEA study (for Leucemies de l’Enfant et de l’Adolescent—childhood and adolescent leukemia) in JOURNAL OF CANCER SURVIVORSHIP
  • 2016-08 Activated PI3-kinase δ Syndrome: Long-term Follow-up after Cord Blood Transplantation in JOURNAL OF CLINICAL IMMUNOLOGY
  • 2016-05 Improved outcome of children transplanted for high-risk leukemia by using a new strategy of cyclosporine-based GVHD prophylaxis in BONE MARROW TRANSPLANTATION
  • 2016-01 Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials in ANNALS OF HEMATOLOGY
  • 2016-01 Should busulfan therapeutic range be narrowed in pediatrics? Experience from a large cohort of hematopoietic stem cell transplant children in BONE MARROW TRANSPLANTATION
  • 2015-11 IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951 in LEUKEMIA
  • 2015-11 Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study in BONE MARROW TRANSPLANTATION
  • 2015-09 Model-Based Determination of Effective Blood Concentrations of Cyclosporine for Neutrophil Response in the Treatment of Severe Aplastic Anemia in Children in THE AAPS JOURNAL
  • 2015-07 Parental smoking, maternal alcohol, coffee and tea consumption during pregnancy, and childhood acute leukemia: the ESTELLE study in CANCER CAUSES & CONTROL
  • 2015-06 Hematopoietic stem cell transplantation in relapsed ALK+ anaplastic large cell lymphoma in children and adolescents: a study on behalf of the SFCE and SFGM-TC in BONE MARROW TRANSPLANTATION
  • 2015-03 Childhood acute lymphoblastic leukaemia and indicators of early immune stimulation: the Estelle study (SFCE) in BRITISH JOURNAL OF CANCER
  • 2014-09 PRKDC mutations associated with immunodeficiency, granuloma and aire-dependent autoimmunity in PEDIATRIC RHEUMATOLOGY
  • 2014-08 Erratum to: Childhood acute leukemia, maternal beverage intake during pregnancy, and metabolic polymorphisms in CANCER CAUSES & CONTROL
  • 2014-03 Impact on long-term OS of conditioning regimen in allogeneic BMT for children with AML in first CR: TBI+CY versus BU+CY: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire in BONE MARROW TRANSPLANTATION
  • 2014-01 An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions in LEUKEMIA
  • 2013-11 Reduced-intensity conditioning followed by allogeneic transplantation in pediatric malignancies: a report from the Société Française des Cancers de l’Enfant and the Société Française de Greffe de Moelle et de Thérapie Cellulaire in BONE MARROW TRANSPLANTATION
  • 2013-04 Childhood acute leukemia, maternal beverage intake during pregnancy, and metabolic polymorphisms in CANCER CAUSES & CONTROL
  • 2013-03 Are ARID5B and IKZF1 polymorphisms also associated with childhood acute myeloblastic leukemia: the ESCALE study (SFCE)? in LEUKEMIA
  • 2013-02 Flow cytometry and IG/TCR quantitative PCR for minimal residual disease quantitation in acute lymphoblastic leukemia: a French multicenter prospective study on behalf of the FRALLE, EORTC and GRAALL in LEUKEMIA
  • 2013-02 Incidence and risk factors of EBV reactivation after unrelated cord blood transplantation: a Eurocord and Société Française de Greffe de Moelle-Therapie Cellulaire collaborative study in BONE MARROW TRANSPLANTATION
  • 2012-12 Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry in ORPHANET JOURNAL OF RARE DISEASES
  • 2012-12 Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE) in LEUKEMIA
  • 2012-12 French “real life” experience of clofarabine in children with refractory or relapsed acute lymphoblastic leukaemia in EXPERIMENTAL HEMATOLOGY & ONCOLOGY
  • 2012-08 Folic acid supplementation, MTHFR and MTRR polymorphisms, and the risk of childhood leukemia: the ESCALE study (SFCE) in CANCER CAUSES & CONTROL
  • 2012-02 Maternal smoking during pregnancy, genetic polymorphisms of metabolic enzymes, and childhood acute leukemia: the ESCALE Study (SFCE) in CANCER CAUSES & CONTROL
  • 2011-03 Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation in LEUKEMIA
  • 2011-03 Links Between Cyclosporin Exposure in Tissues and Graft-Versus-Host Disease in Pediatric Bone Marrow Transplantation: Analysis by a PBPK Model in PHARMACEUTICAL RESEARCH
  • 2010-12 NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951 in LEUKEMIA
  • 2010-12 Influence of Dosing Schedule on Organ Exposure to Cyclosporin in Pediatric Hematopoietic Stem Cell Transplantation: Analysis with a PBPK Model in PHARMACEUTICAL RESEARCH
  • 2010-12 Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009 in ORPHANET JOURNAL OF RARE DISEASES
  • 2010-02 Wilms tumor 1 (WT1) gene mutations in pediatric T-cell malignancies in LEUKEMIA
  • 2009-04 Another pedigree with familial acute myeloid leukemia and germline CEBPA mutation in LEUKEMIA
  • 2008-12 Childhood hematopoietic malignancies and parental use of tobacco and alcohol: the ESCALE study (SFCE) in CANCER CAUSES & CONTROL
  • 2007-08 Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure in BONE MARROW TRANSPLANTATION
  • 2006-12 Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg®) in children with relapsed/refractory myeloid leukemia in BMC CANCER
  • 2006-12 Human herpes virus-6 encephalitis in a paediatric bone marrow recipient: successful treatment with pharmacokinetic monitoring and high doses of ganciclovir in BONE MARROW TRANSPLANTATION
  • 2006-07 Leucémies aiguës lymphoblastiques de l’enfant in ONCOLOGIE
  • 2005-12 Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report in LEUKEMIA
  • 2005-11 Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry in BONE MARROW TRANSPLANTATION
  • 2005-07 The Seventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Palermo, Italy, January 29–30, 2005 in LEUKEMIA
  • 2005-05 Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG in LEUKEMIA
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.413852.9", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "https://www.grid.ac/institutes/grid.413776.0", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.440236.7", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.415550.0", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.14925.3b", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.418199.c", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.415571.3", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.413328.f", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.413959.3", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.139510.f", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.411266.6", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.7849.2", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.461862.f", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.418116.b", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.418936.1", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.452431.5", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.413235.2", 
            "type": "Organization"
            "id": "https://www.grid.ac/institutes/grid.428999.7", 
            "type": "Organization"
        "familyName": "Bertrand", 
        "givenName": "Yves", 
        "id": "sg:person.01077622701.25", 
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:53", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_601.json", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01077622701.25'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01077622701.25'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01077622701.25'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01077622701.25'


    This table displays all metadata directly associated to this object as RDF triples.

    50 TRIPLES      10 PREDICATES      28 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01077622701.25 schema:affiliation N0bf8d63a442249f2a7306ee87f5cf461
    2 https://www.grid.ac/institutes/grid.139510.f
    3 https://www.grid.ac/institutes/grid.14925.3b
    4 https://www.grid.ac/institutes/grid.411266.6
    5 https://www.grid.ac/institutes/grid.413235.2
    6 https://www.grid.ac/institutes/grid.413328.f
    7 https://www.grid.ac/institutes/grid.413776.0
    8 https://www.grid.ac/institutes/grid.413959.3
    9 https://www.grid.ac/institutes/grid.415550.0
    10 https://www.grid.ac/institutes/grid.415571.3
    11 https://www.grid.ac/institutes/grid.418116.b
    12 https://www.grid.ac/institutes/grid.418199.c
    13 https://www.grid.ac/institutes/grid.418936.1
    14 https://www.grid.ac/institutes/grid.428999.7
    15 https://www.grid.ac/institutes/grid.440236.7
    16 https://www.grid.ac/institutes/grid.452431.5
    17 https://www.grid.ac/institutes/grid.461862.f
    18 https://www.grid.ac/institutes/grid.7849.2
    19 schema:familyName Bertrand
    20 schema:givenName Yves
    21 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077622701.25
    22 schema:sdDatePublished 2019-03-07T14:53
    23 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    24 schema:sdPublisher N0373c046ffa2498c9e1e4cc310e1dd05
    25 sgo:license sg:explorer/license/
    26 sgo:sdDataset persons
    27 rdf:type schema:Person
    28 N0373c046ffa2498c9e1e4cc310e1dd05 schema:name Springer Nature - SN SciGraph project
    29 rdf:type schema:Organization
    30 N0bf8d63a442249f2a7306ee87f5cf461 schema:affiliation https://www.grid.ac/institutes/grid.413852.9
    31 sgo:isCurrent true
    32 rdf:type schema:OrganizationRole
    33 https://www.grid.ac/institutes/grid.139510.f schema:Organization
    34 https://www.grid.ac/institutes/grid.14925.3b schema:Organization
    35 https://www.grid.ac/institutes/grid.411266.6 schema:Organization
    36 https://www.grid.ac/institutes/grid.413235.2 schema:Organization
    37 https://www.grid.ac/institutes/grid.413328.f schema:Organization
    38 https://www.grid.ac/institutes/grid.413776.0 schema:Organization
    39 https://www.grid.ac/institutes/grid.413852.9 schema:Organization
    40 https://www.grid.ac/institutes/grid.413959.3 schema:Organization
    41 https://www.grid.ac/institutes/grid.415550.0 schema:Organization
    42 https://www.grid.ac/institutes/grid.415571.3 schema:Organization
    43 https://www.grid.ac/institutes/grid.418116.b schema:Organization
    44 https://www.grid.ac/institutes/grid.418199.c schema:Organization
    45 https://www.grid.ac/institutes/grid.418936.1 schema:Organization
    46 https://www.grid.ac/institutes/grid.428999.7 schema:Organization
    47 https://www.grid.ac/institutes/grid.440236.7 schema:Organization
    48 https://www.grid.ac/institutes/grid.452431.5 schema:Organization
    49 https://www.grid.ac/institutes/grid.461862.f schema:Organization
    50 https://www.grid.ac/institutes/grid.7849.2 schema:Organization

    Preview window. Press ESC to close (or click here)